GAMMA Investing LLC increased its stake in Eli Lilly by 25.8%, now holding 18,000 shares valued at nearly $15 million. This ...

The market for weight management medicines has been the hottest therapeutic area in the past two years. The pharmaceutical giant has far too much going its way. Analysts predict that the weight ...

Water expert warns that tap and bottled water contain harmful chemicals, with 200 million Americans drinking ...

Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...

Citi stated that as the obesity space evolves from injectables to convenient orals, such as orforglipron, the emergence of a ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Several companies across various sectors on the Wall Street have seen some Seeking Alpha analyst activity, including both ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...